| Literature DB >> 24288513 |
Hamid Raieszadeh1, Vahid Noaman, Mehrdad Yadegari.
Abstract
270 Ross broiler chickens of twenty days old were housed in 18-floor pens in a completely randomized design with six treatment groups and three replicate groups and fifteen chicks per each pen. The treatment groups (1-6) consisted of 0, 10, 20, 30, 50, and 70 ppm of nanocide in drinking water, respectively. At 26 days of age, 3 chickens were selected randomly for echocardiography using a 7.5 MHz linear probe, and the left ventricular internal diameter at the end of diastole (LVIDd), left ventricular internal diameter at the end of systole (LVIDs), left ventricular fractional shortening (LVFS), ejection fraction (EF), stroke volume (SV), interventricular septum thickness at the end of systole (IVSTs), and interventricular septum thickness at the end of diastole (IVSTd) were evaluated. LVIDd and LVIDs in group six were of higher rate than other groups and showed statistically significant differences with groups two, three, and four (P < 0.05). LVFS, percentage of EF, and IVSTd were minimum in group six and had significant difference with other groups (P < 0.05). The results of this study showed that prescription of high dosage of nanocide leads to cardiovascular problems with decrease in myocardial contractility and increase in the internal diameter of left ventricle.Entities:
Mesh:
Substances:
Year: 2013 PMID: 24288513 PMCID: PMC3826293 DOI: 10.1155/2013/931432
Source DB: PubMed Journal: ScientificWorldJournal ISSN: 1537-744X
Figure 1Position of transducer which is used for imaging echocardiography in chicken.
Figure 2B-mode and M-mode echocardiography. Left ventricle (LV), right ventricle (RV), left ventricular free wall (LVFW), and wall between the two ventricles (IVS).
Comparison of echocardiographic indices (Means ± Standard deviation) among different chicken groups treated with nanoparticles.
| Treatment groups | Cardiac parameters1 | ||||||
|---|---|---|---|---|---|---|---|
| LVIDd | LVIDs | LVFS | EF | IVSTd | IVSTs | SV | |
| 1 (0 ppm) | 1.08 ± 0.03ab | 0.56 ± 0.02ab | 47.82 ± 0.92a | 83.77 ± 0.98ab | 0.34 ± 0.02a | 0.42 ± 0.02 | 2.19 ± 0.11 |
| 2 (10 ppm) | 1.04 ± 0.02b | 0.51 ± 0.02b | 51.29 ± 1.30a | 85.36 ± 1.62a | 0.32 ± 0.01ab | 0.43 ± 0.03 | 2.02 ± 0.15 |
| 3 (20 ppm) | 1.02 ± 0.01b | 0.50 ± 0.03b | 50.77 ± 3.57a | 85.48 ± 2.41a | 0.32 ± 0.01ab | 0.43 ± 0.01 | 2.09 ± 0.30 |
| 4 (30 ppm) | 1.01 ± 0.02b | 0.53 ± 0.01b | 47.70 ± 0.52ab | 83.05 ± 0.54ab | 0.36 ± 0.01a | 0.40 ± 0.03 | 1.88 ± 0.09 |
| 5 (50 ppm) | 1.03 ± 0.02ab | 0.55 ± 0.06ab | 46.42 ± 5.75ab | 81.61 ± 5.15ab | 0.33 ± 0.03a | 0.36 ± 0.04 | 1.80 ± 0.16 |
| 6 (70 ppm) | 1.09 ± 0.06a | 0.62 ± 0.05a | 42.32 ± 1.82b | 79.40 ± 3.95b | 0.29 ± 0.01b | 0.38 ± 0.01 | 1.84 ± 0.07 |
a-bDifferent superscript letters in each column indicate significant difference between groups (P < 0.05).
Data are reported as mean ± SD.
1LVIDd: left ventricular internal diameter in the end of diastole; LVIDs: left ventricular internal diameter in the end of systole; LVFS: left ventricular fractional shortening; EF: ejection fraction; IVSTd: interventricular septum thickness in the end of diastole; IVSTs: inter ventricular septum thickness in the end of systole; SV: stroke volume.
Figure 3Pericardial effusion in group six.